OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia
Daniela L. Uliana, João Roberto Lisboa, Felipe V. Gomes, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116298-116298
Closed Access | Times Cited: 13

Showing 13 citing articles:

Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders
Noemi Nicosia, M. Giovenzana, Paulina Misztak, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6521-6521
Open Access | Times Cited: 16

Early postnatal NMDA receptor ablation in cortical interneurons impairs affective state discrimination and social functioning
Juan M. Uehara, Mariano Acosta, Estefanía P. Bello, et al.
Neuropsychopharmacology (2025)
Closed Access

Corticolimbic circuitry as a druggable target in schizophrenia spectrum disorders: a narrative review
Abigail Gee, Paola Dazzan, Anthony A. Grace, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access

The Neonatal Microbiome: Implications for Amyotrophic Lateral Sclerosis and Other Neurodegenerations
Andrew Eisen, Matthew C. Kiernan
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 195-195
Open Access

IUPHAR Review - Novel therapeutic targets for schizophrenia treatment: a translational perspective
Veronica Begni, Alessia Marchesin, Marco Andrea Riva
Pharmacological Research (2025), pp. 107690-107690
Open Access

What Remains to Be Discovered in Schizophrenia Therapeutics: Contributions by Advancing the Molecular Mechanisms of Drugs for Psychosis and Schizophrenia
Christoph U. Correll, Massimo Tusconi, Mauro Giovanni Carta, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 906-906
Open Access | Times Cited: 2

Cell type specification and diversity in subpallial organoids
Narciso Pavon, Yubing Sun, ChangHui Pak
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 1

Dysfunctional Parvalbumin Neurons in Schizophrenia and the Pathway to the Clinical Application of Kv3 Channel Modulators
Masaya Yanagi, Mamoru Hashimoto
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8696-8696
Open Access

PV+ optogenetic stimulations at specific frequencies in specific brain regions can restore navigational flexibility in an acute MK801 mouse model of schizophrenia
Enrico Patrono, Daniela Černotová, Jan Svoboda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access

An introduction to the special issue “Sam Enna legacy of Excellence”
Jacques Piette, Lynn LeCount
Biochemical Pharmacology (2024) Vol. 228, pp. 116510-116510
Closed Access

Diazepam modulates hippocampal CA1 functional connectivity in people at clinical high-risk for psychosis
Nicholas R Livingston, Amanda Kiemes, Owen O’Daly, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Page 1

Scroll to top